You are on our international English website. This site features our entire product portfolio worldwide. The products featured may not be available in the US. If you are a citizen from the US, please visit your country website for local information and contacts.
Medical Technology for healthcare professionals
Global website (English)
back
Medical Technology
recommended searches
popular searches
Product

ZEISS miLOOP Removing the challenge of dense cataracts.

The miLOOP® from ZEISS is a game-changing microinterventional lens fragmentation device which is designed to remove the challenges of hard cataracts. Using micro-thin super-elastic, self-expanding nitinol filament technology, the ZEISS miLOOP allows cataract surgeons to achieve zero-energy lens fragmentation for any grade cataract.1

Get in contact with us
  • Reduced phaco energy and fluid use
  • Minimal stress to capsule and zonules
  • Reduced procedure time

Significantly reduce overall phaco energy and fluid use for dense cataracts

A randomized controlled study in the British Journal of Ophthalmology showed that using ZEISS miLOOP in hard grade 3-4+ nuclear cataracts reduces phaco energy by up to 53% and therefore also ultrasonic vibrations. The same study also confirms that using ZEISS miLOOP significantly lowers the surgical irrigation fluid volume used per case by up to 30%.1

Product animation video

Product animation video

Third-party Content Blocked

The video player is blocked due to your tracking preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Apply minimal stress to the capsule and zonules

ZEISS miLOOP is engineered to minimize capsular and zonular stress. It allows out-in nucleus disassembly that directs the force used to divide the lens inwards, while conventional techniques employ in-out lens cutting with adjunct phaco-energy.1

Demonstration video

Demonstration video

Third-party Content Blocked

The video player is blocked due to your tracking preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Reduced procedure time and easier cortical cleanup

In a 2019 surgeon survey, the majority of trained ZEISS miLOOP surgeons report a perceived reduction in overall procedure time with ZEISS miLOOP.2 Furthermore, 84% of the surgeons report an easier cortical cleanup during irrigation/aspiration with the use of ZEISS miLOOP. 2

Clinical case video

Clinical case video

Third-party Content Blocked

The video player is blocked due to your tracking preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Get in touch and learn more!

Receive background information, request a demo or get a quote.

Form is loading...

If you want to have more information on data processing at ZEISS please refer to our data privacy notice.

Maximize your product usage with MyZEISS

ZEISS miLOOP
Product Training5 October 2020

Temporal two-handed approach with two cuts on a dense cataract using ZEISS miLOOP

How-to - 4 min watch
Peer Insights5 August 2021

Intraoperative OCT-guided anterior segment surgery – confirm your surgical decision

On-demand webinar - 56 min watch
Iva Dekaris, Jod S Metha

Exclusive content for you and your teams

Gain exclusive learning content, peer-to-peer content, patient material and access to tools to manage your daily tasks.

Explore more

Specifications

ZEISS miLOOP
Application

lens fragmentation
Phaco energy emitted
none
Cataract range
suitable for any grade cataract
Material
memory shaped super-elastic thin nitinol filament
Length
~15 cm

Get in touch with us!

Form is loading...

Personal contact information

If you want to have more information on data processing at ZEISS please refer to our data privacy notice. 

  • 1

    Ianchulev T, Chang DF, Koo E, et al Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study. British Journal of Ophthalmology April 2018.   
  • 2

    internal user survey, n=279, lantech Data Analytics 20190708 PPT, data on file